Forsidebilde av showet Investors' Chronicle

Investors' Chronicle

Podkast av Investors' Chronicle

engelsk

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden.Avslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Prøv gratis

Les mer Investors' Chronicle

Looking to stay informed in the world of investing? Investors' Chronicle dives into the key trends shaping today’s markets and unpacks what they mean for your investments. Featuring exclusive interviews with professional investors - whether fund managers or leading financial experts - our mission is to help you make smarter investment decisions.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Our award-winning expert writers research hundreds of companies and funds suitable for all risk appetites, to provide clear, independent recommendations for individual investors who want to make their money grow and outline how to make the most of different types of investment vehicles at all stages of your life.Whether you invest in funds or enjoy managing your own portfolio of individual shares, or a mix of both, we offer an unrivalled package of investment ideas, analysis and research, and lots more, to help you build a secure financial future.Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Alle episoder

1161 Episoder

episode Meeting with Fevara’s CEO: Lee and the IC cover

Meeting with Fevara’s CEO: Lee and the IC

Fevara (FVA:127p) may be new in name, but its roots and expertise stretch back more than a century through the former Carr’s Group. In the wake of this major transformation, the livestock supplements company’s focus is now on improving farming productivity through its advanced animal feed technology and supplements, and overseas expansion. Alongside chief executive Joshua Hoopes, Alex Newman and Lord Lee delve into the company’s strategy both at home and in South America. They cover Fevara’s lofty ambitions in Brazil – its acquisitions so far, the competitive advantages of the country, and the company’s targets for long-term growth.  They also discuss why Hoopes believes Fevara can continue growing despite structural changes across the agricultural sector, and issues concerning sustainability and the climate crisis. The trio also explore shareholder returns, dividend policy and the outlook for global cattle markets. Let us know your thoughts, or if you have any questions or any suggestions for future guests, by emailing alex.newman@ft.com [alex.newman@ft.com] TIMESTAMPS 00:00 Intro 02:48 Fevara’s transformation 07:00 Fevara’s feed supplements 17:18 Why Brazil is Fevara’s biggest growth opportunity 27:39 Sustainability, emissions and the future of cattle farming 38:04 Lord Lee’s latest portfolio moves Listen to more podcasts from Investors’ Chronicle by clicking here [https://www.investorschronicle.co.uk/podcasts/] or heading to Apple [https://podcasts.apple.com/gb/podcast/investors-chronicle/id951671327], Spotify [https://open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp] and YouTube [https://www.youtube.com/user/InvestorsChronicle] Investors' Chronicle [https://www.investorschronicle.co.uk/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] has supported private investors in the UK for over 160 years by highlighting rewarding investment [https://www.investorschronicle.co.uk/investment-ideas/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] opportunities. Investors' Chronicle is a service by the Financial Times [https://www.ft.com/?utm_medium=referral&utm_source=acast&utm_campaign=podcast]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

16. juni 2026 - 44 min
episode Investing in photonics, GSK and new opportunities in venture capital: Companies and Markets Show cover

Investing in photonics, GSK and new opportunities in venture capital: Companies and Markets Show

This week’s show dives straight into safety and equipment maker Halma (HLMA), which reported its full-year results [https://www.investorschronicle.co.uk/content/7be3f693-1ef1-4d58-9ad5-d11994c78be6?utm_medium=referral&utm_source=acast&utm_campaign=editorial] on Thursday morning. It may be time to re-evaluate the company’s description as one of the FTSE 100’s least newsworthy businesses – it has been reaping the rewards of the AI boom. But with increased interest comes heightened expectations, and perhaps this is why its shares tumbled by 15 per cent on the day of the results. Mark Robinson digs into the details on whether this ‘quality stock’ is more volatile than it once was. We then turn to big pharma giant GSK (GSK). The drugmaker made its largest deal in over a decade [https://www.investorschronicle.co.uk/content/d0c7e758-1b5e-4c1e-b1d5-b0fa37e446e0?utm_medium=referral&utm_source=acast&utm_campaign=editorial] earlier this week with the acquisition of US cancer biotech Nuvalent. Julian Hofmann takes a look at the $11bn deal and what it means for the future of the pharmaceutical company. Finally we discuss venture capital trust Molten Ventures (GROW), whose investments in the likes of fintech Revolut and microsatellite operator ICEYE have helped boost its returns. Mark is back to explore its portfolio [https://www.investorschronicle.co.uk/content/bdd51831-9445-46b7-8167-438b4e117f99?utm_medium=referral&utm_source=acast&utm_campaign=editorial] and looks at whether the trust is morphing into something different. TIMESTAMPS 00:00 Introduction 01:22 Halma 14:47 GSK 23:06 Molten Ventures 32:25 Outro Listen to more podcasts from Investors’ Chronicle on Apple [https://podcasts.apple.com/gb/podcast/investors-chronicle/id951671327], Spotify [https://open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp] and YouTube [https://www.youtube.com/user/InvestorsChronicle] Investors' Chronicle [https://www.investorschronicle.co.uk/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] has supported private investors in the UK for over 160 years by highlighting rewarding investment [https://www.investorschronicle.co.uk/investment-ideas/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] opportunities. Investors' Chronicle is a service by the Financial Times [https://www.ft.com/?utm_medium=referral&utm_source=acast&utm_campaign=podcast]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

12. juni 2026 - 33 min
episode Investing in British Water, Nick Train & CMC: Companies and Markets Show cover

Investing in British Water, Nick Train & CMC: Companies and Markets Show

This week’s show dives straight into trading platform CMC Markets, after its promise of an imminent inflection point sent its shares soaring [https://www.investorschronicle.co.uk/content/fbb821a8-1ce7-4ef1-9d68-489e96b556b5] to the top of the FTSE All-Share leaderboard on Thursday. Julian Hofmann discusses the business’s full-year figures, its big future plans and whether it’s becoming a more reliable investment. We then turn to this week’s Big Read on how to tap into Britain’s mammoth water plan [https://www.investorschronicle.co.uk/content/5f9ca29d-711e-44c5-9440-e7212805ff47]; the £100bn strategy to shore up and hopefully improve the dismal state of the country’s infrastructure. Will it succeed? And will it lead to new business for contractors and those working on new technologies? Hugh Moorhead has the answers. Finally, we take a look at beleaguered fund manager Nick Train’s latest attempts [https://www.investorschronicle.co.uk/content/886d1b9e-6399-4095-9b6c-6c921fdd78b9?srsltid=AfmBOor_ixOTsQeCUIVRNKTsn3wcapGtZPa-usBlhBmMibaO-u15WOkA] to encourage investors to stick by him during a period of significant underperformance. Holly McKechnie tells us what changes are being made to Finsbury Growth & Income Trust (FGT). Read more here: How investors can tap into Britain’s waterworks plan [https://www.investorschronicle.co.uk/content/5f9ca29d-711e-44c5-9440-e7212805ff47?utm_source=social&utm_medium=youtube&utm_campaign=editorial&utm_content=skip] Will Nick Train’s Finsbury Growth turnaround plan work? [https://www.investorschronicle.co.uk/content/886d1b9e-6399-4095-9b6c-6c921fdd78b9?utm_source=referral&utm_medium=acast&utm_campaign=editorial&utm_content=skip] CMC Markets’ shares jump on upgraded outlook [https://www.investorschronicle.co.uk/content/fbb821a8-1ce7-4ef1-9d68-489e96b556b5?utm_source=referral&utm_medium=acast&utm_campaign=editorial&utm_content=skip] TIMESTAMPS 00:00 Intro 01:08 CMC 13:33 Britain’s waterworks 29:15 Nick Train’s new strategy Listen to more podcasts from Investors’ Chronicle on Apple [https://podcasts.apple.com/gb/podcast/investors-chronicle/id951671327], Spotify [https://open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp] and YouTube [https://www.youtube.com/user/InvestorsChronicle] Investors' Chronicle [https://www.investorschronicle.co.uk/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] has supported private investors in the UK for over 160 years by highlighting rewarding investment [https://www.investorschronicle.co.uk/investment-ideas/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] opportunities. Investors' Chronicle is a service by the Financial Times [https://www.ft.com/?utm_medium=referral&utm_source=acast&utm_campaign=podcast]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

5. juni 2026 - 37 min
episode ‘Bottlenecks are the best way to benefit from AI’: Ali Unwin of Polar Capital Technology cover

‘Bottlenecks are the best way to benefit from AI’: Ali Unwin of Polar Capital Technology

Polar Capital Technology Trust (PCT) is one of the most popular and best-performing tech-focused funds available to DIY investors, having built up its record and fan base long before the likes of AI and ‘Magnificent Seven’ became everyday terms. And deputy manager Ali Unwin has been part of that story since 2021, helping investors access the best and brightest, and yet-to-be-discovered names in the tech world. Val Cipriani sits down with Ali to discuss the fund’s approach in the changing AI space, how to go find the right companies when traditional ways to value stocks are stretched, a world beyond the likes of Nvidia, and plenty more. Investors' Chronicle [https://www.investorschronicle.co.uk/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] has supported private investors in the UK for over 160 years by highlighting rewarding investment [https://www.investorschronicle.co.uk/investment-ideas/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] opportunities. Investors' Chronicle is a service by the Financial Times [https://www.ft.com/?utm_medium=referral&utm_source=acast&utm_campaign=podcast]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

2. juni 2026 - 46 min
episode SpaceX, Pets at Home & defence stocks: Companies and Markets Show cover

SpaceX, Pets at Home & defence stocks: Companies and Markets Show

This week’s show dives straight into Elon Musk’s SpaceX as it gears up for the biggest IPO in market history. We consider what newly released financial details reveal about the company, and whether a mooted $1.75tn valuation is a sign of market madness. Alex Hamer has the details Coming back down to earth, we take a look at Pets at Home. The FTSE 250 retailer has struggled with a mixed outlook and regulatory scrutiny for several years now. But with a former Waitrose boss now in charge, and underlying markets starting to improve, things could be looking up. Valeria Martinez tell us what’s going on Lastly, with the publication of the UK’s 10-year defence spending plan imminent, Michael Fahy examines recent numbers from UK manufacturers Qinetiq and Cohort, and delves into what the future holds for the companies and the wider sector. Read more: SpaceX’s blast-off could burn investors [https://www.investorschronicle.co.uk/content/3514d205-2b96-465c-9e44-d0c98e955148?utm_source=referral&utm_medium=acast&utm_campaign=editorial&utm_content=skip] Pets at Home profits hit by retail price cuts [https://www.investorschronicle.co.uk/content/058f3553-6e8a-4b2a-a74a-b6e1928a61d0?utm_source=referral&utm_medium=acast&utm_campaign=editorial&utm_content=skip] TIMESTAMPS 00:00 Intro 01:03 SpaceX 19:14 Pets at Home 28:00 Defence Listen to more podcasts from Investors’ Chronicle on Apple [https://podcasts.apple.com/gb/podcast/investors-chronicle/id951671327], Spotify [https://open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp] and YouTube [https://www.youtube.com/user/InvestorsChronicle] Investors' Chronicle [https://www.investorschronicle.co.uk/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] has supported private investors in the UK for over 160 years by highlighting rewarding investment [https://www.investorschronicle.co.uk/investment-ideas/?utm_medium=referral&utm_source=acast&utm_campaign=podcast] opportunities. Investors' Chronicle is a service by the Financial Times [https://www.ft.com/?utm_medium=referral&utm_source=acast&utm_campaign=podcast]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

29. mai 2026 - 37 min
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 99 kr / måned

Prøv gratis

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Prøv gratis

Prøv gratis i 14 dager. 99 kr / Måned etter prøveperioden. Avslutt når som helst.